MAPLIGHT THERAPEUTICS APPOINTS KRIS HANSON AS GENERAL COUNSEL

Hanson Brings 25 Years of Experience Advising Public and Private Companies to MapLight as the New Legal and Compliance Leader SAN FRANCISCO and BOSTON, June 20, 2023 /PRNewswire/ — MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.